Skip to main content

Progress against objectives

A globally recognised leader in health research, ageing and related services

2017 Objectives

2 year Progress Review


Develop the North Terrace Health Precinct as the cornerstone of South Australia’s health economy

On track

Reflecting its central location and close links to the local health and biomed sector the Precinct has been renamed the Adelaide BioMed City. Construction of the UniSA and University of Adelaide buildings is nearing completion. The new Royal Adelaide Hospital will provide world-class healthcare and facilities for South Australians.

Increase South Australia’s share of total National Health and Medical Research Council (NHMRC) funding by 20% from it’s 2013 baseline (currently 6.5%)


Total NHRMC funding to South Australia increased from $55.5m in 2013 to $56.1m in 2015. This equates to South Australia's share of NHMRC funding being 6.3% in 2015.

Attract $150m in foreign investment to SA in the life science sector.


Over $150m has been invested in the SA life science sector between the announcement of the 10 Economic Priorities and December 2016.

Support the continued development of the local clinical trials environment, increasing new trial notifications from 66 to 80 by 2017.

Progress made

In the first six months of 2015 there were 57 trial notifications compared with 66 in all of 2014. The State Government is promoting the advantages of South Australia as a destination for clinical trials and working with local stakeholders across the clinical trials sector to enhance and promote Adelaide's clinical trials environment.

Establish a leading tele–health industry encompassing tele–health services, remote monitoring and mobile monitoring

On track

The State Government is working with 10 tele-health and digital health companies to establish or expand local operations and strengthen the local network well as pursuing opportunities to partner with other companies.

Develop South Australia as the health and biomedical cluster for national and international companies, and attract at least three significant companies to the State


MedxBio (GEN1), Somark, Micro-X, Hydrix, Trajan and Pfizer have all been attracted to Adelaide and their operations are creating jobs through the supply chain and supporting economic growth in South Australia.

Develop an international reputation for our high levels of older citizen participation in economic and community life.

Progress made

The Shaping the Future of South Australia Ageing Well Program examined the opportunities around ‘Ageing Well’ for business, government, academia and the community. It involved a five-step process, with over 1,500 participants contributing over the duration of the program in 2016.

Between October-December 2016, over 425 older people participated in 50 community conversations across South Australia as part of the Statewide Conversation with Older South Australians. The outcomes of these conversations will inform the priorities of the Age-Friendly South Australia Strategy, which is intended for launch in May 2017.

Create new products and services for the state and the world, establishing expertise in active ageing

Progress made

The Age of Opportunity Policy Framework has been developed to support South Australians to actively engage in global opportunities offered by the Ageing Well sector.

The Premier’s Ageing Well Innovation Challenge supports local businesses with products and services that meet the growing global demands of the Ageing Well market.

Secure significant health and biomedical conferences in South Australia to promote business–to–business or business–to–research partnering

On track

The AusMedTech 2016 Conference, the August 2016 International Molecular Imaging Symposium, and other health and biomedical conferences were held in Adelaide in 2016.

Create 3500 jobs through the rollout of the National Disability Insurance Scheme.

On track

The South Australian Market Position Statement was published in June 2016. It estimates that the workforce required to service demand will grow from 5,600 - 6,900 FTEs (2016) to 10,200 – 12,600 FTEs by 2019 (average 83% increase). 15,000 additional people are expected to participate in the NDIS by 2019, which will grow the South Australian market from $760m to $1.5bn (97% increase) in the next three years.

Increase international medical equipment and devices exports from $151 million in 2013/14.

On track

Medical devices exports increased from $160m in 2014-15 to $268m in 2015-16 (68% increase).

The medical equipment and device supply chain is being expanded with the presence of Somark, Micro-X, Hydrix, Trajan and SMR Technologies and there are expected to be increasing opportunities for local workers to move into medical device manufacturing and increase local industry capability.